Lifestance Health Group, Inc. key statistics and ratios
In fiscal 2025, Lifestance Health Group, Inc. had return on equity of 0.7%, an operating margin of 1.7%, debt equal to 18.6% of equity and a current ratio of 1.65. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2019Dec 2019 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Operating margin | 7.2% | −42.9% | −24.5% | −17.9% | −2.5% | 1.7% | 4.9% |
| Net margin | 2.7% | −46.0% | −25.1% | −17.6% | −4.6% | 0.7% | 3.2% |
| Free-cash-flow margin | 1.3% | −12.7% | −3.1% | −5.4% | 6.9% | 7.7% | 11.0% |
| Return on equity | — | −44.6% | −14.1% | −12.6% | −4.0% | 0.7% | 3.4% |
| Return on assets | — | −15.9% | −10.5% | −8.7% | −2.7% | 0.4% | 2.3% |
| Asset turnover | — | 0.35 | 0.42 | 0.49 | 0.59 | 0.66 | 0.72 |
| Current ratio | — | 2.28 | 1.33 | 1.11 | 1.37 | 1.65 | 1.38 |
| Debt to equity | — | 10.4% | 15.4% | 20.3% | 20.1% | 18.6% | 18.7% |
| Interest cover (operating income ÷ interest) | 2.8x | n/m | n/m | n/m | n/m | 2.1x | 7.8x |
| Effective tax rate | 28.0% | — | — | — | — | 21.8% | 24.5% |
| SG&A as % of revenue | 19.3% | 65.0% | 44.0% | 38.9% | 29.0% | 26.8% | 25.2% |
| Capital spending as % of revenue | 6.7% | 14.2% | 9.2% | 3.8% | 1.7% | 2.5% | 2.8% |
| Free cash flow ÷ net income | 48.2% | — | — | — | — | >999% | 343.7% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 0.0% | 0.3% | 0.5% | −0.9% | 2.0% | 4.7% | 5.5% | 7.0% |
| Net margin | 0.2% | −2.2% | 0.2% | −1.1% | 0.3% | 3.1% | 3.5% | 5.4% |
| Free-cash-flow margin | 5.7% | 17.2% | −3.1% | 16.4% | 4.7% | 12.2% | 5.5% | 20.2% |
| Current ratio | 1.32 | 1.37 | 1.47 | 1.48 | 1.58 | 1.65 | 1.48 | 1.38 |
| Debt to equity | 19.6% | 19.8% | 19.6% | 19.3% | 18.9% | 18.4% | 19.0% | 18.5% |
| SG&A as % of revenue | 27.3% | 28.8% | 28.4% | 28.2% | 26.3% | 24.8% | 24.9% | 24.8% |
Financial health
- Short-term assets cover short-term liabilities $378m of assets due within a year against $275m of liabilities due within a year.
- Short-term assets cover long-term liabilities $378m short-term assets against $430m of longer-dated liabilities.
- More cash than debt $226m of cash against $273m of debt.
- Debt below 40% of shareholders' equity Debt is 19% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 10% to 19% over five years.
- A year's operating cash flow covers at least 20% of debt $218m of operating cash flow against $273m of debt.
- Operating profit covers interest at least five times over Operating income of $78m against $10m of interest.
Moat
Weak moat
How hard Lifestance Health Group's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Net income has been a median -5.8% of total assets over 6 years.
- Durability 10 / 20
Operating margin has been a median -10.0%; its worst year was -46.8%.
- Cash conversion 3 / 20
Free cash flow was positive in 2 of 6 years, at a median -1.4% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (22 before it).
Compare with peers
- P3 Health Partners Inc. statistics
- Addus Homecare Corp statistics
- Healthequity, Inc. statistics
- Progyny, Inc. statistics
- Evolent Health, Inc. statistics
Head to head: LFST vs PIIIADUS vs LFSTHQY vs LFST
More: Health Care Services stocks compared, Health Care sector, rankings of US companies